Polypharmacy and frailty: Prevalence, relationship, and impact on mortality in a French sample of 2350 old people

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 6, 2015, Pages 637-646

  Herr, Marie ^a,b   Robine, Jean Marie ^c   Pinot, Juliette ^a,b   Arvieu, Jean Jacques ^d   Ankri, Joël ^a,b  

^a UMR S 1168   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d Accidents et Risques Divers   (France)

Author keywords

Aged; Drugs; Frailty; Pharmacoepidemiology; Polypharmacy; Survival

Indexed keywords

AGED; ARTICLE; BODY MASS; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; FRAIL ELDERLY; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITION; PHARMACOEPIDEMIOLOGY; PHYSICAL ACTIVITY; POLYPHARMACY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STRENGTH; VERY ELDERLY; WALKING SPEED; WEIGHT REDUCTION; ELDERLY CARE; EPIDEMIOLOGY; FRANCE; GERIATRIC ASSESSMENT; STATISTICS AND NUMERICAL DATA; TRENDS;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FRAIL ELDERLY; FRANCE; GERIATRIC ASSESSMENT; HEALTH SERVICES FOR THE AGED; HUMANS; MALE; MORTALITY; POLYPHARMACY; PREVALENCE;

EID: 84930417978     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3772     Document Type: Article

References (56)

1. Bradley MC, Motterlini N, Padmanabhan S, et al. Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr 2014; 14: 72. doi:10.1186/1471-2318-14-72.
2. Fialova D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 2009; 67(6): 641-645. doi:10.1111/j.1365-2125.2009.03419.x.
3. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62(10): 1172-1181.
4. Jyrkka J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2011; 20(5): 514-522. doi:10.1002/pds.2116.
5. Wallace E, Stuart E, Vaughan N, Bennett K, Fahey T, Smith SM. Risk prediction models to predict emergency hospital admission in community-dwelling adults: a systematic review. Med Care 2014; 52(8): 751-765. doi:10.1097/MLR.0000000000000171.
6. Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf 2014; 23(7): 753-758. doi:10.1002/pds.3624.
7. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009; 26(12): 1039-1048. doi:10.2165/11319530-000000000-00000.
8. Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 2011; 28(7): 547-560. doi:10.2165/11592000-000000000-00000.
9. Franchi C, Cartabia M, Risso P, et al. Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project. Eur J Clin Pharmacol 2013; 69(7): 1477-1483. doi:10.1007/s00228-013-1495-7.
10. Tamura BK, Bell CL, Inaba M, Masaki KH. Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med 2012; 28(2): 217-236. doi:10.1016/j.cger.2012.01.005.
11. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381(9868): 752-762. doi:10.1016/S0140-6736(12)62167-9.
12. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146-M156.
13. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011; 27(1): 17-26. doi:10.1016/j.cger.2010.08.008, pii:S0749-0690(10)00082-0.
14. Cesari M, Gambassi G, van Kan GA, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing 2014; 43(1): 10-12. doi:10.1093/ageing/aft160.
15. Shamliyan T, Talley KM, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev 2013; 12(2): 719-736. doi:10.1016/j.arr.2012.03.001.
16. Chang CI, Chan DC, Kuo KN, Hsiung CA, Chen CY. Prevalence and correlates of geriatric frailty in a northern Taiwan community. J Formos Med Assoc 2011; 110(4): 247-257. doi:10.1016/S0929-6646(11)60037-5, pii:S0929-6646(11)60037-5.
17. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012; 91(3): 521-528. doi:10.1038/clpt.2011.258, pii:clpt2011258.
18. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008; 64(2): 183-199. doi:10.1007/s00228-007-0422-1.
19. Gnjidic D, Hilmer SN. Potential contribution of medications to frailty. J Am Geriatr Soc 2012; 60(2): 401. doi:10.1111/j.1532-5415.2011.03810.x.
20. Hubbard RE, O'Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol 2013; 69(3): 319-326. doi:10.1007/s00228-012-1387-2.
21. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65(9): 989-995. doi:10.1016/j.jclinepi.2012.02.018, pii:S0895-4356(12)00084-4.
22. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17(1): 37-49.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-198.
24. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-919.
25. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9(3): 179-186.
26. Hurtig-Wennlof A, Hagstromer M, Olsson LA. The International Physical Activity Questionnaire modified for the elderly: aspects of validity and feasibility. Public Health Nutr 2010; 13(11): 1847-1854. doi:10.1017/S1368980010000157.
27. Castrejon-Perez RC, Borges-Yanez SA, Gutierrez-Robledo LM, Avila-Funes JA. Oral health conditions and frailty in Mexican community-dwelling elderly: a cross sectional analysis. BMC Public Health 2012; 12: 773. doi:10.1186/1471-2458-12-773, pii:1471-2458-12-773.
28. Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc 2013; 61(9): 1537-1551. doi:10.1111/jgs.12420.
29. Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci 2007; 62(7): 731-737. pii:62/7/731.
30. Herr M, Arvieu JJ, Aegerter P, Robine JM, Ankri J. Unmet health care needs of older people: prevalence and predictors in a French cross-sectional survey. Eur J Public Health 2013. doi:10.1093/eurpub/ckt179.
31. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009; 26(6): 493-503. doi:10.2165/00002512-200926060-00006.
32. Comptes nationaux de la santé 2012. Direction de la Recherche, de l'Evaluation et des Etudes Statistiques, 2013. Available at: http://www.drees.sante.gouv.fr/IMG/pdf/comptes_nationaux_sante_2010.pdf [September 2014].
33. Drey M, Wehr H, Wehr G, et al. The frailty syndrome in general practitioner care: a pilot study. Z Gerontol Geriatr 2011; 44(1): 48-54. doi:10.1007/s00391-010-0136-3.
34. Miguel RC, Dias RC, Dias JM, da Silva SL, Menicucci Filho PR, Ribeiro TM. Frailty syndrome in the community-dwelling elderly with osteoarthritis. Rev Bras Reumatol 2012; 52(3): 331-347. pii:S0482-50042012000300004.
35. Ernsth Bravell M, Westerlind B, Midlov P, et al. How to assess frailty and the need for care? Report from the Study of Health and Drugs in the Elderly (SHADES) in community dwellings in Sweden. Arch Gerontol Geriatr 2010; 53(1): 40-45. doi:10.1016/j.archger.2010.06.011, pii:S0167-4943(10)00176-7.
36. Bennett A, Gnjidic D, Gillett M, et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging 2014; 31(3): 225-232. doi:10.1007/s40266-013-0151-3.
37. Ferrer A, Badia T, Formiga F, Sanz H, Megido MJ, Pujol R. Frailty in the oldest old: prevalence and associated factors. J Am Geriatr Soc 2013; 61(2): 294-296. doi:10.1111/jgs.12154.
38. Castell MV, Sanchez M, Julian R, Queipo R, Martin S, Otero A. Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care. BMC Fam Pract 2013; 14(1): 86. doi:10.1186/1471-2296-14-86, pii:1471-2296-14-86.
39. Crentsil V, Ricks MO, Xue QL, Fried LP. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 2010; 8(3): 215-224. doi:10.1016/j.amjopharm.2010.06.003, pii:S1543-5946(10)00044-9.
40. Clarfield AM. Screening in frail older people: an ounce of prevention or a pound of trouble? J Am Geriatr Soc 2010; 58(10): 2016-2021. doi:10.1111/j.1532-5415.2010.03070.x.
41. De Breucker S, Herzog G, Pepersack T. Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation? A retrospective observational study. Drugs Aging 2011; 27(10): 807-813. doi:10.2165/11537900-000000000-00000, pii:4.
42. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Patterson C. Development of an easy prognostic score for frailty outcomes in the aged. Age Ageing 2008; 37(2): 161-166. doi:10.1093/ageing/afm195, pii:afm195.
43. de Vries NM, Staal JB, Olde Rikkert MG, Nijhuis-van der Sanden MW. Evaluative frailty index for physical activity (EFIP): a reliable and valid instrument to measure changes in level of frailty. Phys Ther 2013; 93(4): 551-561. doi:10.2522/ptj.20120127.
44. Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 2008; 11(1): 151-161. doi:10.1089/rej.2007.0569.
45. Schuurmans H, Steverink N, Lindenberg S, Frieswijk N, Slaets JP. Old or frail: what tells us more? J Gerontol A Biol Sci Med Sci 2004; 59(9): M962-M965. pii:59/9/M962.
46. van Mourik Y, Moons KG, Bertens LC, Reitsma JB, Hoes AW, Rutten FH. Triage of frail elderly with reduced exercise tolerance in primary care (TREE). A clustered randomized diagnostic study. BMC Public Health 2012; 12: 385. doi:10.1186/1471-2458-12-385, pii:1471-2458-12-385.
47. Muntinga ME, Hoogendijk EO, van Leeuwen KM, et al. Implementing the chronic care model for frail older adults in the Netherlands: study protocol of ACT (frail older adults: care in transition). BMC Geriatr 2012; 12: 19. doi:10.1186/1471-2318-12-19, pii:1471-2318-12-19.
48. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006; 35(5): 526-529. doi:10.1093/ageing/afl041.
49. Louis ED, Benito-Leon J, Vega S, Bermejo-Pareja F. Frailty in elderly persons with essential tremor: a population-based study (NEDICES). Eur J Neurol 2011; 18(10): 1251-1257. doi:10.1111/j.1468-1331.2011.03374.x.
50. van Kempen JA, Schers HJ, Melis RJ, Olde Rikkert MG. Construct validity and reliability of a two-step tool for the identification of frail older people in primary care. J Clin Epidemiol 2014; 67(2): 176-183. doi:10.1016/j.jclinepi.2013.08.008.
51. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14(6): 392-397. doi:10.1016/j.jamda.2013.03.022.
52. Tjia J, Velten SJ, Parsons C, Valluri S, Briesacher BA. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 2013; 30(5): 285-307. doi:10.1007/s40266-013-0064-1.
53. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012; 5: CD008165. doi:10.1002/14651858.CD008165.pub2.
54. Poudel A, Hubbard RE, Nissen L, Mitchell C. Frailty: a key indicator to minimize inappropriate medication in older people. QJM 2013; 106(10): 969-975. doi:10.1093/qjmed/hct146.
55. Proposal for a regulation of the European parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC.
56. Gnjidic D, Le Couteur DG, Hilmer SN. Discontinuing drug treatments. BMJ 2014; 349: g7013. doi:10.1136/bmj.g7013.